ATE175358T1 - Behandlung des prämenstruellen oder späten lutealsphase-syndroms - Google Patents

Behandlung des prämenstruellen oder späten lutealsphase-syndroms

Info

Publication number: ATE175358T1
Authority: AT; Austria
Prior art keywords: treatment; premenstrual; luteal phase; phase syndrome; late luteal
Prior art date: 1987-10-22

Application number

AT88910336T

Other languages

English (en)

Inventor

Richard J Wurtman

Judith J Wurtman

Original Assignee

Massachusetts Inst Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-22

Filing date

1988-10-21

Publication date

1999-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26809210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE175358(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-09-15 Priority claimed from US07/244,944 external-priority patent/US4971998A/en

1988-10-21 Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology

1999-01-15 Application granted granted Critical

1999-01-15 Publication of ATE175358T1 publication Critical patent/ATE175358T1/de

Links

101100020619 Arabidopsis thaliana LATE gene Proteins 0.000 title 1
230000029849 luteinization Effects 0.000 title 1
208000011580 syndromic disease Diseases 0.000 title 1
239000000203 mixture Substances 0.000 abstract 2
DBGIVFWFUFKIQN-VIFPVBQESA-N (+)-Fenfluramine Chemical compound CCN[C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-VIFPVBQESA-N 0.000 abstract 1
RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 abstract 1
206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
230000036528 appetite Effects 0.000 abstract 1
235000019789 appetite Nutrition 0.000 abstract 1
229960004597 dexfenfluramine Drugs 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229960002464 fluoxetine Drugs 0.000 abstract 1
230000036651 mood Effects 0.000 abstract 1
230000002295 serotoninergic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Conversion Of X-Rays Into Visible Images (AREA)
Pyrane Compounds (AREA)

AT88910336T 1987-10-22 1988-10-21 Behandlung des prämenstruellen oder späten lutealsphase-syndroms ATE175358T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11177187A	1987-10-22	1987-10-22
US07/244,944 US4971998A (en)	1987-10-22	1988-09-15	Methods for treating the premenstrual or late luteal phase syndrome

Publications (1)

Publication Number	Publication Date
ATE175358T1 true ATE175358T1 (de)	1999-01-15

Family

ID=26809210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88910336T ATE175358T1 (de)	1987-10-22	1988-10-21	Behandlung des prämenstruellen oder späten lutealsphase-syndroms

Country Status (5)

Country	Link
EP (1)	EP0386117B1 (de)
JP (1)	JP2938463B2 (de)
AT (1)	ATE175358T1 (de)
DE (1)	DE3856295T2 (de)
WO (1)	WO1989003692A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5011688A (en) *	1989-02-02	1991-04-30	Calam Henry D	Liquid composition for the relief of premenstrual and menstrual discomforts
US4962128A (en) *	1989-11-02	1990-10-09	Pfizer Inc.	Method of treating anxiety-related disorders using sertraline
EP0449562A3 (en) *	1990-03-29	1992-03-18	Eli Lilly And Company	Use of r-fluoxetine as selective serotonin ic-receptor ligands
US5589511A (en) *	1990-08-13	1996-12-31	Sepracor Inc.	Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) *	1991-02-04	1998-01-13	Sepracor Inc.	Methods of use and compositions of R(-) fluoxetine
IL100889A (en) *	1991-02-15	1997-03-18	Ciba Geigy Ag	Nootropic and nerve- regenerative pharmaceutical compositions comprising 4-(7-bromo- 5-methoxybenzofuran-2-yl) piperidine
US5455254A (en) *	1991-02-15	1995-10-03	Mondadori; Cesare	Substituted benzofuranylpiperidine as a nootropic agent
FR2685204B1 (fr) *	1991-12-19	1995-06-16	Palmer Research	Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
ATE392893T1 (de) *	1993-06-28	2008-05-15	Wyeth Corp	Neue behandlungsmethoden durch verwendung von phenethylaminderivaten
AU707142B2 (en)	1994-06-03	1999-07-01	David R. Elmaleh	Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
AU765173B2 (en) *	1998-04-24	2003-09-11	Scarista Limited	Treatment of depression and pharmaceutical preparations therefor
US7034059B2 (en)	2001-07-02	2006-04-25	Sepracor Inc.	Methods of using norfluoxetine
EP2305230B1 (de) *	2001-12-05	2015-11-04	Teva Women's Health, Inc.	Orale Verhütungsmittel zum Verhindern einer Schwangerschaft
US20070111975A1 (en)	2004-10-07	2007-05-17	Duramed Pharmaceuticals, Inc.	Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
JP2016516732A (ja)	2013-03-18	2016-06-09	エボニックレームゲゼルシャフトミットベシュレンクテルハフツングＥｖｏｎｉｋＲｏｅｈｍＧｍｂＨ	メタクリル酸及びメタクリル酸エステルの製造方法
EP3608305A1 (de)	2018-08-10	2020-02-12	Röhm GmbH	Verfahren zur herstellung von methacrylsäure oder methacrylsäureestern

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4210637A (en) *	1978-07-31	1980-07-01	Massachusetts Institute Of Technology	Composition and method for suppressing appetite for calories as carbohydrates
US4309445A (en) *	1980-06-16	1982-01-05	Massachusetts Institute Of Technology	d-Fenfluramine for modifying feeding behavior
GB2129299A (en) *	1982-11-09	1984-05-16	Alec James Coppen	Pharmaceutical compositions
US4590213A (en) *	1983-04-08	1986-05-20	Eli Lilly And Company	Anti-anxiety method
US4649161A (en) *	1986-06-16	1987-03-10	Massachusetts Institute Of Technology	Method for treating depression with d-fenfluramine

1988
- 1988-10-21 AT AT88910336T patent/ATE175358T1/de not_active IP Right Cessation
- 1988-10-21 EP EP88910336A patent/EP0386117B1/de not_active Expired - Lifetime
- 1988-10-21 DE DE3856295T patent/DE3856295T2/de not_active Expired - Fee Related
- 1988-10-21 WO PCT/US1988/003709 patent/WO1989003692A1/en not_active Ceased
- 1988-10-21 JP JP63509530A patent/JP2938463B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO1989003692A1 (en)	1989-05-05
EP0386117A1 (de)	1990-09-12
DE3856295D1 (de)	1999-02-18
EP0386117B1 (de)	1999-01-07
JPH03500884A (ja)	1991-02-28
JP2938463B2 (ja)	1999-08-23
DE3856295T2 (de)	1999-06-17

Similar Documents

Publication	Publication Date	Title
ATE175358T1 (de)	1999-01-15	Behandlung des prämenstruellen oder späten lutealsphase-syndroms
ATE128864T1 (de)	1995-10-15	Zusammensetzung zur behandlung der symptome verursacht durch beseitigung von tabak.
DE3483040D1 (de)	1990-09-27	Maschinelesbares dokument und dessen behandlung.
NO900837L (no)	1990-08-24	Hylster til roekeartikler og fremgangsmaate til dets behandling.
NL300066I2 (nl)	2002-06-03	Behandeling van zwaarlijvigheid.
DE69202207D1 (de)	1995-06-01	Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan.
ATE163195T1 (de)	1998-02-15	Lösliche liganden für cd40
DE3870508D1 (de)	1992-06-04	Zusammensetzung zur behandlung des haares.
BE816419A (fr)	1974-10-16	Pr0cede de reduction de la teneur en vapeurs nitreuses des effluents gazeux nitreux
NO873699L (no)	1988-03-10	Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
NO964238L (no)	1996-10-04	Halofantrin-fri-base for behandling av malaria og blandinger
AT378675B (de)	1985-09-10	Tisch, hocker oder stuhl und verfarhen zur herstellung desselben
NO900358L (no)	1990-08-01	Fremgangsmaate og innretning for behandling av faststoff-gass-blandinger som skal pumpes.
IT8719763A0 (it)	1987-03-19	Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
PT66089A (en)	1977-02-01	Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect,application of same for the preparation of pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis
PT71408A (de)	1980-07-01	Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
IT7926382A0 (it)	1979-10-10	Trattamento del gas di spurgo nella sintesi della ammoniaca.
CA2002182A1 (en)	1991-05-03	Compositions for treating the premenstrual or late luteal phase syndrome and methods for their use
IL58103A0 (en)	1979-12-30	Sila-substituted 1,4-dihydropyridine derivatives their production and pharmaceutical compositions containing them
NL7612682A (nl)	1977-05-17	Werkwijze en inrichting voor de warmtebehande- ling van waren, alsmede waren behandeld onder toepassing van de werkwijze.
DE3676640D1 (de)	1991-02-07	Prazosin-pirbuterol-mischung zur bronchendilatation.
IT8420682A0 (it)	1984-04-20	Procedimento per il trattamento di articoli di maglieria.
ATE130304T1 (de)	1995-12-15	Neue alpha-glukosidaseinhibitoren.
IT7825497A0 (it)	1978-07-10	Derivati di 1,2,4-ossadiazolo, loro preparazione e loro applicazione in terapia.
ATE122886T1 (de)	1995-06-15	Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht.

Legal Events

Date	Code	Title	Description
2001-04-15	UEP	Publication of translation of european patent specification
2008-07-15	REN	Ceased due to non-payment of the annual fee